Drug establishment registration
Revance Therapeutics, Inc.
FDA drug establishment · DUNS 118195550 · FEI 3007772056 · USA
Key facts
| Firm name | Revance Therapeutics, Inc. |
|---|---|
| DUNS number | 118195550 |
| FEI number | 3007772056 |
| Address | 7555 Gateway Boulevard, Newark, California (CA) 94560, United States (USA) |
| Country | USA |
| Business operations | ANALYSIS, API MANUFACTURE, MANUFACTURE |
| Registration valid through | Dec 31, 2027 |
At a glance
- Current Registration current
- 1–9 FDA inspections at this FEI
- 1–9 Inspections with a Form 483
- None Warning letters
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug establishment registrations
Establishments that manufacture, repack, relabel or analyze drugs for the U.S. market register with the FDA each year. The registration lists the site's DUNS and FEI numbers and its business operations.
Source: U.S. Food and Drug Administration (FDA), Drug Establishments Current Registration Site (DECRS)